Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Imraldi

Imraldi 40 mg solution for injection in pre-filled syringe Imraldi 40 mg solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 118–119

HOS-226095 · Präparat HOS-217512

118 System organ class Frequency Adverse reaction Uncommon Diplopia Ear and labyrinth Common Vertigo disorders Uncommon Deafness, tinnitus Cardiac disorders* Common Tachycardia Uncommon Myocardial infarction1), arrhythmia, congestive heart failure Rare Cardiac arrest Vascular disorders Common Hypertension, flushing, haematoma Uncommon Aortic aneurysm, vascular arterial occlusion, thrombophlebitis Respiratory, thoracic Common Asthma, and mediastinal dyspnoea, disorders* cough Uncommon Pulmonary embolism1), interstitial lung disease, chronic obstructive pulmonary disease, pneumonitis, pleural effusion1) Rare Pulmonary fibrosis1) Gastrointestinal Very Abdominal pain, disorders common nausea and vomiting Common GI haemorrhage, dyspepsia, gastroesophageal reflux disease, sicca syndrome Uncommon Pancreatitis, dysphagia, face oedema Rare Intestinal perforation1) Hepatobiliary Very Elevated liver enzymes disorders* common Uncommon Cholecystitis and cholelithiasis, hepatic steatosis, bilirubin increased Rare Hepatitis reactivation of hepatitis B1) autoimmune hepatitis1) Not Known Liver failure1) Skin and Very Rash (including exfoliative rash) subcutaneous tissue common disorders Common Worsening or new onset of psoriasis (including palmoplantar pustular psoriasis)1), urticaria, bruising (including purpura), dermatitis (including eczema), onychoclasis, hyperhidrosis, alopecia1), pruritus Uncommon Night sweats,

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.